ClinicalTrials.gg
Status unknownNCT01961193COMLENPLSTANUpdated Oct 11, 2013

A Comparison Between Bandage Contact Lens, Punctal Plugs and Standard Measures in Preventing Corneal Injuries

An interventional study of contact lens and punctal plug in Contact Lens and Punctal Plug in Preventing Corneal Injuries, sponsored by Rabin Medical Center. Status unknown at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-10-11.

Sponsored by Rabin Medical Center · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Oct 2013), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
105
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Study Rationale:

The insertion of a bandage contact lens or punctal plug in a defined group of patients admitted to the ICU may be more effective than standard care in decreasing the incidence of corneal injuries.

Study Objectives:

  1. To document the effect of a contact bandage lens and punctal plug in preventing corneal injuries in critically ill patients admitted to the ICU.
  2. To assess the safety of a contact bandage lens and punctal plug in critically ill patients.
Read the detailed description

This is a prospective, randomized study

Study Population:

Consecutive patients admitted to the General Intensive Care Unit of the Rabin Medical Center and Sharon Hospital Medical Center over a 6-month period who meet criteria for inclusion.

Procedures:

Consecutive patients meeting inclusion criteria will be enrolled in the study. Patients will be randomized to 3 groups: the bandage contact lens group, who will be assigned to insertion of a bandage contact lens; the punctal plug group, who will be assigned to the insertion of punctal plugs; and the control group, who will be assigned to standard eye care as currently practiced in the ICU.

In addition, patients in the study will be examined every 4 days by a physician from the ophthalmology department and at either discharge from the ICU or at time of death.

02

Conditions studied

  • Contact Lens and Punctal Plug in Preventing Corneal Injuries

Browse trials for

Keywords

  • critically ill patients
  • punctal plug
  • corneal injuries
03

In context

Corneal Injuries

33 studies on the registry are indexed under Corneal Injuries; 9 are open to participants now.

This study's planned enrollment of 105 is above the median of 43 across 25 interventional studies indexed under Corneal Injuries.

Browse Corneal Injuries studies →

Lead sponsor

Rabin Medical Center is the lead sponsor of 393 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Patients must be > 18 years of age. Patients who meet the following criteria will be considered eligible for the study: i) require mechanical ventilation; ii) require continuous infusion of sedative medication with or without neuromuscular paralysis; iii) anticipated ICU stay > 5 days.

Exclusion criteria

Exclusion Criteria:

- Patients will be excluded if there is any preexisting corneal disease or an ophthalmic injury related to the present admission (e.g. ophthalmic trauma) to the ICU.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
105 participants (estimated)

Study arms

  • Experimental
    bandage contact lens

    A bandage contact lens will be inserted by a physician from the ophthalmology department within the first 24 hours of admission of the patient to the ICU. The position of the lens will be confirmed. The lens will remain in-situ as long as the patient is considered to require artificial lubrication or until discharge from the intensive care unit.

    Device: contact lens

  • Experimental
    punctal plug

    A punctal plug (Painless Silicon Plugs),will be inserted into each eye. Lubricant drops will be instilled four times daily into each eye. The punctal plug will remain in- situ as long as the patient is considered to require artificial lubrication or until discharge from the intensive care unit at which time it will be removed by a physician from the ophthalmology department.

    Device: punctal plug

  • No intervention
    Control group

    Hydroxyethylcellulose drops will be inserted into each eye four times a day and erythromycin ophthalmic ointment will be applied three times a day as well.

Interventions

  • Devicecontact lens

    A bandage contact lens will be inserted by a physician from the ophthalmology department within the first 24 hours of admission of the patient to the ICU. The position of the lens will be confirmed. The lens will remain in-situ as long as the patient is considered to require artificial lubrication or until discharge from the intensive care unit.

    Also known as: contact bandage lens

  • Devicepunctal plug

    A punctal plug will be inserted into each eye. Lubricant drops ethylcellulose) will be instilled four times daily into each eye. The punctal plug will remain in-situ as long as the patient is considered to require artificial lubrication or until discharge from the intensive care unit at which time it will be removed by a physician from the ophthalmology department.

    Also known as: Painless Silicon Plugs

06

What researchers measure

Primary outcomes

  1. Presence or absence of corneal damage

    To document the effect of a contact bandage lens and punctal plug in preventing corneal injuries in critically ill patients admitted to the ICU.

    Time frame: From date of randomization until date of dischrage from ICU or date of death from any cause whichever came first assessed up to 2 months.

Secondary outcomes

  1. Presence of infection

    Results of bacterial cultures

    Time frame: From date of randomization until date of dischrage from ICU or date of death from any cause whichever came first assessed up to 2 months

07

Study locations

1 site
  • Rabin MC Beilinson
    Petah Tikva, 49100, Israel
    • Jonathan Cohen, MD Professor · Contact · jonatanc@gmail.com · 97239376524
    • Milana Grinev, RN Study Coordinator · Contact · milang@clalit.org.il · 97239376521
    • Pierre Singer, MD, Prof · Sub investigator
    • Jonathan Cohen, MD Prof · Principal investigator
    • Shaul Lev, MD · Sub investigator
    • Milana Grinev, RN · Sub investigator
    • Inbal Avisar, MD · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2015, a primary completion of Jul 2015 and a completion of Jul 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2013
First posted
Oct 11, 2013
Start
May 2015
Primary completionEst.
Jul 2015
CompletionEst.
Jul 2015
Last update
Oct 11, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 11, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01961193
Responsible party
jonatan cohen (Prof.Jonathan Cohen, Rabin Medical Center) — Principal investigator
First posted
Oct 11, 2013
Start date
May 2015
Primary completion
Jul 2015 (estimated)
Completion
Jul 2015 (estimated)
Last update
Oct 11, 2013

Study contacts

Jonathan Cohen, MD Prof
Contact
jonatanc@clalit.org.il
9729376524
Milana Grinev, Study Coordinator
Contact
milang@clalit.org.il
97239376521
Jonathan Cohen, MD Prof
principal investigator · ICU dep't , Rabin MC Campus Beilinson

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion